摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Bromo-2'-[3-chloro-4-(2-methyl(thiobenzoyl))-phenylamino]butananilide | 321371-67-9

中文名称
——
中文别名
——
英文名称
4-Bromo-2'-[3-chloro-4-(2-methyl(thiobenzoyl))-phenylamino]butananilide
英文别名
4-bromo-N-[2-[3-chloro-4-(2-methylbenzenecarbothioyl)anilino]phenyl]butanamide
4-Bromo-2'-[3-chloro-4-(2-methyl(thiobenzoyl))-phenylamino]butananilide化学式
CAS
321371-67-9
化学式
C24H22BrClN2OS
mdl
——
分子量
501.874
InChiKey
XTPBOKPOSLTGCW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.6
  • 重原子数:
    30
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    73.2
  • 氢给体数:
    2
  • 氢受体数:
    3

文献信息

  • AMINOBENZOPHENONES AS INHIBITORS OF IL-1BETA AND TNF-ALPHA
    申请人:LEO PHARMACEUTICAL PRODUCTS LTD. A/S(LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB)
    公开号:EP1210320A1
    公开(公告)日:2002-06-05
  • US6566554B1
    申请人:——
    公开号:US6566554B1
    公开(公告)日:2003-05-20
  • [EN] AMINOBENZOPHENONES AS INHIBITORS OF IL-1 beta AND TNF- alpha<br/>[FR] AMINOBENZOPHENONES EN TANT QU'INHIBITEURS DE IL-1 beta ET TNF- alpha
    申请人:LEO PHARM PROD LTD
    公开号:WO2001005746A1
    公开(公告)日:2001-01-25
    The present invention relates to a compound of general formula (I) wherein R1, R2, and R3 represents one or more, same or different substituents selected from the group consisting of halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1-C3)alkyl, (C2-C3)olefinic group, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, cyano, -CONH2, phenyl, or nitro; further R2 can be hydrogen, and R3 can be carboxy and carbamoyl; R4 represents hydrogen, (C1-C3)alkyl, or allyl; X represents oxygen or sulphur; Q represents -(CO)-, -(CS)-, or a bond; Y represents (C5-C15)alkyl; (C2-C15)olefinic group; (C3-C10)monocyclic hydrocarbon group; or phenyl; any of which may be optionally substituted by one or more, same or different substituents selected from the group consisting of the formula R5 defined below; (C1-C4)alkyl substituted by one or more substituents selected for the group R5; or a group of the formula -(Z-O)n-Z, wherein Z is a (C1-C3)alkyl, n is an integer > 1; and no continuous linear sequence of atoms in the group Y exceeds 15; R5 represents halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, cyano, azido, nitro, -COOH, -CONH2, -CONHR', or COONR'R' wherein R' represents (C1-C3)alkyl; or a pharmaceutically acceptable salt thereof, or a hydrate or solvate thereof. The compounds are valuable in the human and veterinary therapy.
查看更多